— Know what they know.
Not Investment Advice
Also trades as: PLX.TA (TLV) · $vol 0M

PLX AMEX

Protalix BioTherapeutics, Inc.
1W: +1.5% 1M: -7.7% 3M: -33.7% YTD: +16.7% 1Y: +18.0% 3Y: -6.5% 5Y: -25.9%
$2.10
+0.07 (+3.45%)
 
Weekly Expected Move ±5.6%
$2 $2 $2 $2 $2
AMEX · Healthcare · Biotechnology · Alpha Radar Sell · Power 46 · $169.2M mcap · 72M float · 1.32% daily turnover · Short 43% of daily vol

📊 Key Metrics

TTM
$76M
Revenue
+27.8% YoY
$15M
Net Income
+292.3% YoY
$15M
Free Cash Flow
+1036.9% YoY
87.8%
Gross Margin
62.7%
Op. Margin
54.3%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE33.5%
ROA19.7%
ROIC37.6%

Valuation

P/E10.9
P/B2.5
EV/EBITDA7.9

Leverage

Debt/Equity0.17
Current Ratio2.51
Interest Cov.13.2x

Quality Scores

Piotroski F7/9
Altman Z-1.05
Beneish M-0.80

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms